| Media Release On Vitamin C Launch |
Intimation Under Reg 30 Of Sebi (Lodr) |
| Board Of Directors |
Code Of Conduct |
| Investor Information |
Terms And Condition Of Appointment Of Independent Director |
| Notice Regarding Change Of Rta. |
Press Release |
| Press Release — Launches Vaginal Spray |
Press Release On Ndds Formulation Ondansetron Oral Spray (Domi Up) |
| A.G.M.-2016 Scrutinizer Report |
Agm-2017 Scrutinizer Report |
| Press Release For Awardwd Patent Antimalarial Drug. |
Details Of Nodal Officer Under Iepf |
| Appointment Of Director On The Board Of The Company |
Intimation Of Regulation 30 Of Sebi, Lodr |
| Dematerialization Of Physical Securities |
A.G.M. – 2018 – Scrutinizer Report |
| Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information |
A.G.M. -2019 Scrutinizer Report |
| Press Release On Patent |
Change In Officials Of Determining The Materiality Of Events |
| Media Release On Eu Gmp |
Disclousre On Material Impact Of Covid-19 |
| Media Release On Vitamin C Launch |
Intimation Under Reg 30 Of Sebi (Lodr) |
|
|
